Quantification of Apixaban, Dabigatran, Edoxaban, and Rivaroxaban in Human Serum by UHPLC-MS/MS—Method Development, Validation, and Application
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Pharmacology (medical),Pharmacology
Reference20 articles.
1. Non-vitamin K antagonist oral anticoagulants in cardiovascular disease management: evidence and unanswered questions;Cheng;J Clin Pharm Ther.,2014
2. New oral anticoagulants in patients with nonvalvular atrial fibrillation: a review of pharmacokinetics, safety, efficacy, quality of life, and cost effectiveness;Mani;Drug Des Devel Ther.,2014
3. New oral anticoagulants: clinical indications, monitoring and treatment of acute bleeding complications;Fenger-Eriksen;Acta Anaesthesiol Scand.,2014
4. The effect of dabigatran plasma concentrations and patient characteristics on the frequency of ischemic stroke and major bleeding in atrial fibrillation patients: the RE-LY Trial (Randomized Evaluation of Long-Term Anticoagulation Therapy);Reilly;J Am Coll Cardiol.,2014
5. Importance of pharmacokinetic profile and variability as determinants of dose and response to dabigatran, rivaroxaban, and apixaban;Gong;Can J Cardiol.,2013
Cited by 37 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Apixaban plasma concentrations before and after catheter ablation for atrial fibrillation;PLOS ONE;2024-07-31
2. Development and validation of an ultrafast method of quantification of rivaroxaban in human serum using laser diode thermal desorption coupled to triple quadrupole mass spectrometry;Rapid Communications in Mass Spectrometry;2024-07-11
3. A highly sensitive and selective electrochemical sensing probe for detection of Edoxaban anticoagulant drug residue in environmental water and drug formulations;International Journal of Environmental Analytical Chemistry;2024-07-08
4. Development and Validation of an HPLC-MS/MS Method for Quantification of Apixaban in Human Plasma;Drug development & registration;2024-02-20
5. A rapid and sensitive analytical methodology for the simultaneous biomonitoring of two direct oral anticoagulant drugs and their major metabolites in thromboembolic disordered patients samples for clinical evaluations;Journal of Chromatography A;2024-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3